Related Experiment Video

Updated: Jun 5, 2026

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

Hematology: Bortezomib and dexamethasone induction for multiple myeloma

Jacob Laubach, Paul Richardson

    Nature Reviews. Clinical Oncology
    |December 24, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
    09:41

    An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

    Published on: July 15, 2015

    Related Experiment Videos

    Last Updated: Jun 5, 2026

    Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
    05:32

    Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

    Published on: January 7, 2019

    An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
    09:41

    An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

    Published on: July 15, 2015

    Related Concept Videos

    Bone Marrow Sampling and Transplants01:22

    Bone Marrow Sampling and Transplants

    Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
    The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

    Articles linked to this work by shared authors, journal, and citation graph.

    The HPTN 094 Peer Navigation Model: Integration of Substance Use Treatment and HIV Prevention and Care for People Who Inject Drugs.

    Journal of addiction medicine·2026

    Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma.

    The New England journal of medicine·2026

    ACTIVE involvement in alcohol care: a community case study in coproduction.

    Frontiers in public health·2026

    The application of fluorinated α-amino acids to drug discovery techniques.

    Expert opinion on drug discovery·2026

    Isatuximab: an anti-CD38 therapy that addresses unmet needs and mechanisms of resistance in multiple myeloma.

    Expert opinion on investigational drugs·2026

    Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trial.

    Nature medicine·2026

    Exploring the landscape of targetable alterations in patients with glioblastoma.

    Nature reviews. Clinical oncology·2026

    AI-based augmentation of oncology clinical trials.

    Nature reviews. Clinical oncology·2026

    Clinical toxicity of ADCs and ICI-ADC combinations: mechanisms, patterns and management.

    Nature reviews. Clinical oncology·2026

    De-escalation trials in multiple myeloma: past, present and future.

    Nature reviews. Clinical oncology·2026

    Towards liquid biopsy-based analysis of antitumour immunity.

    Nature reviews. Clinical oncology·2026

    CRISPR in clinical oncology: translational advances from molecular diagnostics to therapeutics.

    Nature reviews. Clinical oncology·2026

    Regulatory T cells in intracerebral hemorrhage: mechanisms of immunomodulation and therapeutic potential.

    Frontiers in immunology·2026

    Fc-engineering for improved cancer immunotherapy.

    Biochemical Society transactions·2026

    Explosive Multiterritorial Arterial Thrombosis Following Brief Heparin Exposure: A Diagnostic Pitfall in the Cath Lab.

    Case reports in cardiology·2026

    Lipophilic Ligand Efficiency-Monitored Discovery of Potent, Achiral, and Bioavailable Apo-IDO1 Inhibitors.

    ACS medicinal chemistry letters·2026

    Telitacicept for IgA nephropathy: a systematic review and meta-analysis of observational studies.

    Frontiers in medicine·2026

    Envafolimab - novel anti-PD-1/PD-L1 antibody in cancer treatment.

    Frontiers in immunology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us